Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies (2017)
- Authors:
- USP affiliated authors: NAKAYA, HELDER TAKASHI IMOTO - FCF ; ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Subjects: MELANOMA; PELE
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 53, suppl. 1, p. 10 res. FCF016, 2017
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
OLIVEIRA, Erica Aparecida de et al. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 25 fev. 2026. , 2017 -
APA
Oliveira, E. A. de, Fernandes, D. K. A., Flores, F. F., Lima, D. S. de, Cardozo, L. E., Nakaya, H. T. I., & Maria-Engler, S. S. (2017). Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2026 fev. 25 ] -
Vancouver
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2026 fev. 25 ] - Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1
- Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1
- Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells
- Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of DM-1 compound toxicity in melanoma cells
- Resenha sem título próprio
- Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression
- Oxidative stress triggered by apigenin induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines
- Estudo destaca potencial do jucá contra rugas e manchas na pele
- Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development
- Assessing the effects of advanced glycation end products in the skin
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
